Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
BioLoomics
BioLoomics is a biotechnology company focused on developing safer and more effective cancer therapies by engineering Antibody Drug Conjugates (ADCs). They utilize a directed evolution approach,…
BioLoomics
BioLoomics is a biotechnology company focused on developing safer and more effective cancer therapies by engineering Antibody Drug Conjugates (ADCs). They utilize a directed evolution approach,…
TL;DR
What they do: Develop directed-evolution engineered Antibody Drug Conjugates (Super-ADCs) and antibody–peptide chimera modalities for oncology
Stage & funding: Seed-stage; announced $8.7M seed round (Sep 19, 2023); total reported funding ≈ $10.1M
Location: Boulder, Colorado
Team size: ~16 employees
Company Overview
Problem Domain
Oncology therapeutics; improving specificity and efficacy of antibody drug conjugates and related antibody-based modalities.
Founded
2019
Industry
Biotechnology
Funding Track Record
8.7M
Company announced $8.7M seed financing to advance platform and antibody degrader programs
Investor Signal
“Led by Innovation Endeavors with participation from Horizons Ventures, TechU Ventures, Boom Capital Ventures, Hummingbird/Nomads Fund, BoxOne Ventures, Cooley GC&H, and Viswa Colluru”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week